1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The impact of COVID-19 on aflibercept treatment of neovascular AMD in Sweden – data from the Swedish Macula Register
(
- Contribution to journal › Article
- 2022
-
Mark
Electrophysiological evaluation and 18-month follow-up of two regimens with aflibercept for neovascular age-related macular degeneration
(
- Contribution to journal › Article
- 2008
-
Mark
Full-field ERG and visual fields in patients 5 years after discontinuing vigabatrin therapy.
(
- Contribution to journal › Article